Physicochemical and functional assessment of messenger RNA 5′Cap-end impurities under forced degradation conditions
Year: 2025
Type: article
Abstract: using model mRNAs with elevated impurity levels. mRNA 5'Cap degradation impurities significantly impacted protein expression but did not trigger innate immune response pathways. 5'Cap degradation impurities should be considered as a critical quality attribute of mRNA therapeutics and should be monitored during production, purification, formulation, and storage.
Authors: J. Hutchinson, F. Schweikart, R. Shannon, A. Murthy, S.M. Bates, S. Leone, T. Nissan, D. Sideris, C. Lal, J. Button, R. Rani, G. Thom, N. Bond, E. Örnskov, S. Trabulo
Institutions: AstraZeneca (United Kingdom), AstraZeneca (Sweden)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,900
Funders: AstraZeneca Mölndal, AstraZeneca
OpenAlex ID: W4410540595
